Medivir to present at the DNB Nordic Healthcare Conference

Stockholm, Sweden, 2024 — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today announces that the company will present at the DNB Nordic Healthcare Conference in Oslo on November 26.

CEO Jens Lindberg will provide an update on the fostrox program in advanced hepatocellular carcinoma (HCC). The presentation will include the recently presented data at the ESMO conference and how they strengthen the ambition to make fostrox + Lenvima® the first, approved treatment option in second-line HCC.

 
The presentation will be available on Medivir’s website after the meeting.

For more information about the event, please visit DNB Nordic Healthcare Conference.

Datum 2024-11-25, kl 10:30
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.